Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• The stem-like phenotype in cancer is linked to epithelial-mesenchymal transition (EMT).
• EMT-inducing factors are implicated in cancer stem cell (CSC) generation.
• Mechanisms of EMT in head and neck squamous cell carcinoma (HNSCC) stemness are not well understood.

Purpose of the Study:

• To investigate the role of slug, a major EMT effector, in the stemness of HNSCC cells.
• To determine if slug manipulation affects HNSCC stem cell phenotypes in vitro and in vivo.
• To correlate slug expression levels with patient prognosis.

Main Methods:

• In vitro experiments involving slug gene manipulation (overexpression and knockdown) in HNSCC cells.
• Assessment of stemness phenotypes: self-renewal (sphere formation), stem cell marker expression, chemoresistance, and invasion.
• In vivo studies using a HNSCC xenograft mouse model to evaluate tumorigenicity and invasion.
• Analysis of slug expression in patient samples to correlate with prognosis.

Main Results:

• Slug overexpression enhanced HNSCC cell self-renewal, stemness marker expression, and cisplatin chemoresistance.
• Slug promoted HNSCC cell migration and invasion in vitro and in vivo.
• Slug knockdown abrogated self-renewal, stemness gene expression, and chemoresistance.
• High slug expression levels correlated with poor prognosis in HNSCC patients.

Conclusions:

• Slug plays a critical role in promoting stem-like properties and chemoresistance in HNSCC.
• Slug expression is a potential biomarker for predicting HNSCC patient prognosis.
• Targeting slug may represent a novel therapeutic strategy for HNSCC.